tiprankstipranks
NextPlat (NXPL)
NASDAQ:NXPL
US Market
Want to see NXPL full AI Analyst Report?

NextPlat (NXPL) Earnings Dates, Call Summary & Reports

95 Followers

Earnings Data

Report Date
Aug 17, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
-0.07
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 14, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call communicates a clear and measurable operational turnaround: substantial margin expansion, sharply reduced operating losses, the healthcare segment returning to profitability, growth in higher-margin pharmacy contract revenue, and stabilized e-commerce performance. These positive developments are counterbalanced by meaningful declines in top-line revenue (both YoY and sequential), an ongoing legal matter, prior Nasdaq compliance actions (reverse split) and the potential dilution implied by an ATM facility. On balance, the improvements in profitability, margins, and segment-level performance are material and portrayed as sustainable catalysts for future growth, outweighing the remaining revenue and corporate governance headwinds.
Company Guidance
Guidance: management expects operational profitability in the latter half of 2026 with meaningful reductions in operating losses in H2 as new higher‑margin 340B and medication‑fulfillment customers ramp (the company signed five new 340B agreements this quarter that require ~90 days to onboard and are expected to contribute in Q3) and a new e‑commerce healthcare site is slated to go live before the end of Q2. Key metrics supporting that guidance: Q1 net revenues ≈ $10.0M (healthcare ≈ $7.0M, e‑commerce ≈ $3.2M; healthcare ≈ 68% of revenue), pharmacy contract revenue ≈ $1.9M (vs $1.6M in Q4’25 and $1.4M year‑ago), average 7,500 prescriptions filled/month to Florida contract facilities, consolidated gross profit ≈ $3.4M and gross margin ≈ 35% (vs ~21% in Q1’25 and ~18% in Q4’25), pharmacy gross margin ≈ 39% (vs ~20% prior year), total operating expenses ≈ $4.5M (salaries ≈ $2.4M), operating loss ≈ $1.1M (improved from ~$2.1M year‑ago and ~$2.8M Q4’25), cash ≈ $11M and working capital ≈ $14M; management also cited nationwide expansion to all 50 states, record IoT/e‑commerce demand across 130+ countries, and an ATM facility in place for optional capital although there are no current plans to access it.
Significant Gross Margin Expansion
Consolidated gross margin expanded to approximately 35% in Q1 2026, up from ~21% in Q1 2025 (+14 percentage points YoY) and up from ~18% in Q4 2025 (+17 percentage points sequential). Consolidated gross profit rose to ~$3.4M (from ~$2.9M YoY, +17.2%).
Substantial Reduction in Operating Loss
Operating loss improved to approximately $1.1M in Q1 2026, versus ~$2.1M in the prior year period (improvement of ~$1.0M, -47.6% YoY) and versus ~$2.8M in Q4 2025 (-60.7% sequential).
Healthcare Segment Turned Profitable
Healthcare operations generated positive segment operating income of approximately $24k in Q1 2026, a swing from a segment operating loss of ~$1.2M in Q4 2025 and ~ $0.9M loss in the prior year period, validating turnaround efforts in the segment.
Pharmacy Margin and Contract Momentum
Pharmacy gross margin improved to ~39% in Q1 2026 versus ~20% in the prior year (improvement of ~19 percentage points). Pharmacy contract revenue grew to ~$1.9M (from ~$1.4M YoY, +35.7% YoY; and from ~$1.6M in Q4 2025, +18.8% sequential).
E-commerce Stability and International Demand
E‑commerce revenue was approximately $3.2M in Q1 2026, up ~6.7% YoY from ~$3.0M. Sales were generated across customers in 130+ countries with record highs in IoT sales and recurring revenue and several European government/military orders building a multiyear pipeline.
Operational Cost Discipline
Total operating expenses decreased to ~$4.5M in Q1 2026 versus ~$4.9M YoY (-8.2%) and versus ~$5.3M in Q4 2025 (-15.1%). Salaries and wages fell to ~$2.4M (down ~11.1% YoY and ~14.3% sequential).
Healthy Liquidity and Balance Sheet Flexibility
Ended the quarter with approximately $11M in cash and ~$14M in working capital, with no meaningful debt. Management established an ATM program to provide optional capital flexibility for potential growth or M&A (no immediate plans to access).
New Customer Wins and Fulfillment Volume
Secured five new 340B pharmacy service agreements in a single quarter (company record) currently onboarding (~90 days to start contributing) and filled an average of ~7,500 prescriptions per month for contract facilities in Florida, driving recurring service fees and margin improvements.

NextPlat (NXPL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NXPL Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 17, 2026
2026 (Q2)
- / -
-0.069
May 14, 2026
2026 (Q1)
- / -0.42
-0.51718.76% (+0.10)
Mar 31, 2026
2025 (Q4)
- / -0.41
-0.51719.73% (+0.10)
Nov 13, 2025
2025 (Q3)
- / -0.80
-2.263.64% (+1.40)
Aug 14, 2025
2025 (Q2)
- / -0.69
-0.282-144.33% (-0.41)
May 15, 2025
2025 (Q1)
- / -0.52
-0.079-554.43% (-0.44)
Mar 24, 2025
2024 (Q4)
- / -1.16
-0.907-28.11% (-0.25)
Nov 14, 2024
2024 (Q3)
- / -2.20
0.184-1295.65% (-2.38)
Aug 14, 2024
2024 (Q2)
- / -2.82
-2.402-17.44% (-0.42)
May 15, 2024
2024 (Q1)
- / -
-0.082
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

NXPL Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 14, 2026
$6.41$6.26-2.26%
Mar 31, 2026
$4.71$3.72-21.02%
Nov 13, 2025
$7.58$6.75-10.96%
Aug 14, 2025
$7.84$7.02-10.42%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does NextPlat (NXPL) report earnings?
NextPlat (NXPL) is schdueled to report earning on Aug 17, 2026, TBA (Confirmed).
    What is NextPlat (NXPL) earnings time?
    NextPlat (NXPL) earnings time is at Aug 17, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NXPL EPS forecast?
          Currently, no data Available